Caris Life Sciences, Inc. 4

Denton John Russel had 6,047 shares of Caris Life Sciences, Inc. common stock withheld to cover taxes on RSU vesting, retaining over 190,000 shares directly and indirectly.

On May 15, 2026, Denton John Russel, Senior Vice President, General Counsel, and Secretary of Caris Life Sciences, Inc., had 6,047 shares of common stock withheld by the company at an implied price of $15.25 per share to satisfy tax obligations arising from the vesting and settlement of restricted stock units (RSUs). This is a routine, tax-related Form 4 transaction coded as an "F" (payment of tax with securities), rather than an open-market sale, leaving him with 181,515 shares held directly and an additional 9,184 shares held indirectly in a trust. Based on the implied price, his direct holdings are valued at approximately $2.77 million, and his indirect trust holdings at about $140,000, indicating he retains a substantial equity position following this compensatory share withholding.

Filing Facts

CIK

2019410

Ticker

CAI

Form

4

Source Type

fda

Accession

0002071923-26-000005

Alert Tier

5